Skip to main content
. 2020 Aug 28;21(17):6243. doi: 10.3390/ijms21176243

Figure 5.

Figure 5

Increase of fibroblast growth factor21 (FGF21) level by the administration of pemafibrate in the STZ-induced diabetic mouse model. (A) Quantitative analysis showed that pemafibrate increased serum FGF21 level in STZ-induced diabetic mice (n = 5–6 per group). (B) Quantitative analysis showed that pemafibrate slightly increased Fgf21 mRNA level in STZ-induced diabetic livers (n = 6–7 per group). (C) Quantitative analysis showed that pemafibrate did not increase Fgf21 mRNA level in STZ-induced diabetic retinas (n = 9–12 per group). * p < 0.05. Graphs are presented as median with interquartile range, the 25th and 75th percentile. The data were analyzed using Student’s t-test.